The progressive decline of skeletal muscle mass, strength, and function, a condition known as sarcopenia, represents a pervasive and often debilitating aspect of human aging. This insidious degradation typically commences relatively early in adulthood, culminating in a cascade of adverse health outcomes for older individuals. Beyond the noticeable reduction in physical capabilities and increased frailty, the physiological consequences include heightened scarring within muscle tissue, the unwelcome infiltration of adipose cells, and a significant reduction in fast-twitch muscle fibers—those crucial for rapid, powerful movements essential for maintaining balance, agility, and overall mobility. This age-associated muscular deterioration profoundly impacts independence, quality of life, and contributes substantially to the global burden of healthcare expenditures.
Addressing this fundamental challenge, a team of researchers led by Professor Ryuichi Tatsumi at Kyushu University’s Faculty of Agriculture has unveiled a significant discovery that offers a novel avenue for mitigating age-related muscle impairment. Their recent findings, published on July 24, 2026, in the esteemed journal Scientific Reports, detail the identification of a specific molecule capable of safeguarding and amplifying a pivotal protein integral to the body’s intrinsic muscle repair mechanisms. This research offers a fresh perspective on combating the cellular impediments that undermine regenerative capacity in aging tissues.
Central to the body’s sophisticated machinery for muscular regeneration is a potent signaling protein known as hepatocyte growth factor, or HGF. Under normal physiological circumstances, HGF exists in a quiescent state, embedded within the intricate extracellular matrix that forms the structural scaffolding surrounding muscle fibers. This dormant form ensures that the powerful regenerative signals are only activated precisely when required. When muscle tissue experiences injury, trauma, or even specific types of mechanical stimulation, this latent HGF is liberated from its structural confines. Upon release, it embarks on its critical mission: to bind with specific receptors, known as c-Met, located on the surface of satellite cells. These specialized stem cells are the unsung heroes of muscle maintenance and repair, residing in a quiescent state beneath the basal lamina of muscle fibers, poised for activation. The binding of HGF to c-Met acts as the critical "on" switch, rousing these dormant satellite cells. Once activated, they embark on a rigorous program of proliferation, differentiation, and ultimately, fusion with damaged muscle fibers or formation of new ones, thereby orchestrating the meticulous process of tissue rebuilding and regeneration.
However, the efficiency of this elegant repair system becomes compromised with advancing age. Prior investigations conducted by Professor Tatsumi’s group illuminated a key vulnerability: HGF itself can undergo a detrimental chemical alteration termed nitration. This process involves the covalent attachment of a nitro group to two specific tyrosine residues on the HGF protein, identified as Y198 and Y250. Critically, these two sites are strategically located within the very region of the HGF molecule responsible for its interaction and binding with the c-Met receptor. Once nitration occurs, the HGF protein’s ability to effectively dock with its c-Met receptor is severely impaired. The research team aptly described this functional compromise using the analogy of a "rusted key" that no longer perfectly fits its corresponding "lock." This diminished functional capacity of HGF, brought about by nitration, is posited as one of the fundamental molecular drivers contributing to the widespread muscle wasting and impaired regenerative potential observed in older adults.
Professor Tatsumi elaborated on this crucial insight, stating, "It’s not necessarily that HGF is absent or produced in insufficient quantities as we age. Rather, the challenge lies in its susceptibility to chemical modification after its synthesis. This observation naturally led us to hypothesize whether a compound possessing robust antioxidant properties might offer a protective shield for HGF, either by directly preventing the nitration process or by somehow mitigating the functional deficits it imposes." This critical research question pivoted the team towards exploring potential therapeutic interventions.
Guided by this hypothesis, the scientists turned their attention to a distinct class of molecules known as trisulfides, characterized by a unique chemical structure featuring three sulfur atoms linked in a linear sequence. Specifically, they investigated two compounds within this class: glutathione trisulfide (GSSSG) and lipoic acid trisulfide (LASSS). These particular trisulfides have garnered increasing interest within the pharmaceutical research community, not only for their distinctive sulfur chemistry but also for their notable capacity to engage in vital redox reactions—chemical processes involving the transfer of electrons that are fundamental to cellular health and defense against oxidative stress.
Initial laboratory experiments, meticulously designed to evaluate the antioxidant capabilities of these compounds, revealed promising results. Both GSSSG and LASSS demonstrated an ability to significantly reduce the extent of nitration occurring at the critical Y198 and Y250 sites on the HGF protein. This indicated a protective effect against the chemical modification. However, despite this reduction in nitration, neither compound fully succeeded in restoring HGF’s original, unimpaired capacity to bind to its c-Met receptor. The "rusted key" was less rusted, but still not perfectly fitting the lock. This led the researchers to explore the effects of varying concentrations. They subsequently increased the molar ratio of HGF to the trisulfide compounds, escalating from a ratio of 1:4000 to a higher concentration of 1:8000.
This adjustment in concentration yielded a truly remarkable and entirely unexpected outcome, particularly with LASSS. When HGF was exposed to and mixed with LASSS at the higher molar ratio, its ability to bind to the c-Met receptor experienced a dramatic surge, rising to more than double that observed in untreated HGF. Furthermore, the protein exhibited a significantly enhanced resistance to the functional degradation typically induced by nitration, with this protective effect being especially pronounced at the Y198 site. Intriguingly, this unprecedented enhancement was observed exclusively with LASSS; GSSSG, despite its similar antioxidant properties and trisulfide structure, did not elicit the same profound effect.
Professor Tatsumi expressed his astonishment: "This outcome far surpassed our initial expectations. We were aware that trisulfides possess a diverse array of biological functions, but we genuinely never anticipated that a simple admixture of HGF with LASSS could produce such a striking and potent effect on its binding affinity." He further elaborated on the implications of this discovery: "What this strongly suggests is that LASSS operates beyond the mere neutralization of reactive oxygen species. It appears to engage in a direct interaction with HGF itself, likely inducing a subtle yet significant structural alteration within the protein. This interaction seems to create an enhanced, perhaps even ‘Super HGF,’ form that not only binds with greater avidity to c-Met but also exhibits increased resilience against detrimental nitration." This hypothesis points towards a sophisticated mechanism where LASSS acts not just as a shield, but potentially as a molecular sculptor, optimizing HGF’s inherent function.
To transition these compelling in vitro observations into a more biologically relevant context, the research team proceeded to evaluate the protective efficacy of LASSS within a living organism. They conducted experiments using a well-established mouse model of muscle atrophy, specifically induced by tail suspension—a method known to simulate the muscle wasting effects of prolonged inactivity or microgravity. The results from these in vivo studies provided further validation: mice that received treatment with LASSS prior to the tail suspension procedure displayed significantly reduced levels of HGF nitration compared to their untreated counterparts. Consistent with the laboratory findings, GSSSG failed to confer any measurable protective benefits in this animal model. These findings underscore the critical point that the beneficial effects of LASSS are not confined to isolated proteins in a test tube but extend to functional outcomes within living biological systems. However, the researchers cautiously note that extensive additional studies, particularly involving aging animals, will be indispensable to rigorously ascertain the safety profile and therapeutic efficacy of LASSS in vivo.
The groundbreaking discovery of LASSS’s capacity to enhance and protect HGF signaling holds immense promise for the development of innovative strategies aimed at preserving muscle integrity and function throughout the aging process. Beyond age-related sarcopenia, this approach could offer critical support for individuals enduring extended periods of bed rest, chronic inactivity due to illness, or other conditions that invariably lead to significant muscle loss. The researchers are optimistic that the beneficial effects observed with LASSS on HGF are not species-specific and may translate across a broad spectrum of organisms, including humans and even companion animals such as cats and dogs, where age-related muscle decline also impacts quality of life.
In the foreseeable future, this scientific breakthrough could pave the way for novel therapeutic interventions that empower individuals to maintain robust muscular strength, sustain their independence, significantly enhance their overall quality of life, and ultimately extend their healthy lifespan as they advance in years. The implications for public health and individual well-being are profound, offering a glimmer of hope in the ongoing quest to combat the multifaceted challenges of biological aging. The path forward involves rigorous clinical development, but the foundational science has laid a compelling groundwork for a new era in regenerative medicine.
About the Author
